m hwA

Becky Levine MedThink Communications

N.C. firm/UNMC partner to investigate potential new drugs

RESEARCH TRIANGLE PARK, N.C. — Addrenex Pharmaceuticals, Inc. has signed a licensing agreement with UNeMed Corporation, the technology transfer arm of UNMC, giving Addrenex exclusive rights to the medical center’s library of nearly 400 compounds that target “adrenergic” receptors — docking sites on cells that react with the hormones adrenalin and noradrenalin.

Dec 21, 2007